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The Androgen Receptor Antagonizes Wnt/β-Catenin
Signaling in Epidermal Stem Cells
Kai Kretzschmar1,2,5, Denny L. Cottle2,3, Pawel J. Schweiger2,4,6 and Fiona M. Watt1
Activation of Wnt/β-catenin signaling in adult mouse epidermis leads to expansion of the stem cell compartment
and redirects keratinocytes in the interfollicular epidermis and sebaceous glands (SGs) to differentiate along the
hair follicle (HF) lineages. Here we demonstrate that during epidermal development and homeostasis there is
reciprocal activation of the androgen receptor (AR) and β-catenin in cells of the HF bulb. AR activation reduced β-
catenin-dependent transcription, blocked β-catenin-induced induction of HF growth, and prevented β-catenin-
mediated conversion of SGs into HFs. Conversely, AR inhibition enhanced the effects of β-catenin activation,
promoting HF proliferation and differentiation, culminating in the formation of benign HF tumors and a
complete loss of SG identity. We conclude that AR signaling has a key role in epidermal stem cell fate selection
by modulating responses to β-catenin in adult mouse skin.
Journal of Investigative Dermatology (2015) 135, 2753–2763; doi:10.1038/jid.2015.242; published online 16 July 2015
INTRODUCTION
Adult mammalian epidermis is maintained by self-renewing
stem cells, which reside in distinct locations and give rise to
progeny that differentiate along the lineages of the hair follicle
(HF), sebaceous gland (SG), and interfollicular epidermis (IFE;
Owens and Watt, 2003; Fuchs, 2009; Watt and Jensen, 2009).
During normal epidermal homeostasis, each stem cell
population produces the differentiating cells that are appro-
priate for its speciﬁc location (Kretzschmar and Watt, 2014).
However, in response to injury or genetic manipulation, stem
cells in any region of the epidermis have the ability to give rise
to all differentiated epidermal lineages (Watt and Jensen,
2009; Arwert et al., 2012)
Canonical Wnt signaling has a major role in regulating
epidermal stem cell renewal and lineage selection (Blanpain
et al., 2007; Watt and Collins, 2008). The onset and duration
of Wnt signaling can be controlled by expressing a
4-hydroxytamoxifen (4-OHT) inducible form of stabilized
β-catenin under the control of the keratin 14 (K14) promoter
in the basal layer of transgenic mouse epidermis (K14ΔNβ-
cateninER mice). Studies with this model have shown that a
single application of 4-OHT induces existing HFs to enter the
growth phase of the hair cycle (anagen), whereas repeated
treatments result in expansion of the stem cell compartment
and reprogramming of cells in the SG and IFE to form ectopic
HFs (Van Mater et al., 2003; Lo Celso et al., 2004; Silva-
Vargas et al., 2005). The cells at the base of the SG are
particularly sensitive to β-catenin activation, whereas the stem
cells in the HF bulge are resistant (Baker et al., 2010;
Deschene et al., 2014).
β-catenin is highly regulated through binding partners and
cross-talk with other signaling pathways (Clevers and Nusse,
2012). One such partner is the androgen receptor (AR), which
interacts with β-catenin in an androgen-dependent manner
(Yang et al., 2002; Song et al., 2003). Androgen-bound AR
can inhibit β-catenin target gene expression (Chesire and
Isaacs, 2002; Pawlowski et al., 2002) as a result of
competition with TCF/LEF1 transcription factors for β-
catenin binding (Mulholland et al., 2003; Terry et al., 2006).
In the epidermis, AR and enzymes of androgen metabolism
are expressed in SGs and HFs (Randall et al., 1993; Miyake
et al., 1994; Rosenﬁeld et al., 1998; Itami and Inui, 2005;
Rosenﬁeld, 2005). AR activation can promote MYC-induced
SG differentiation (Cottle et al., 2013) and inhibit hair growth
(Naito et al., 2008; Crabtree et al., 2010). Regulation of
androgen expression and AR signaling is implicated in
androgenetic alopecia (AGA), a common form of hair loss
that occurs in men and women (Paus and Cotsarelis, 1999),
and a reciprocal relationship between β-catenin and AR
signaling has been observed in co-cultures of human dermal
papilla (DP) cells and HF stem cells isolated from healthy and
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AGA individuals (Leirós et al., 2012). These observations
led us to investigate whether the AR modulates the
responsiveness of epidermal cells to β-catenin activation.
RESULTS
Cellular localization of AR and β-catenin in cycling HFs
Although the AR is expressed in adult skin (Cottle et al.,
2013), it is only active when localized to the cell nucleus
(Azzi et al., 2006). AR usually localizes to the cell nucleus
in humans and rodents that have not undergone castra-
tion (Robel et al., 1983). In line with this observation, in
neonatal skin (postnatal day 2), the AR was localized to the
nucleus in all epidermal and dermal cells, except for
epidermal cells in the hair bulb, where it was present in the
cytoplasm (Figure 1a). Although in some bulb cells the AR
appeared to be concentrated at the cell periphery, the AR is
Neonatal (P2) Anagen (P23)
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
DA
PI
/A
R
/β-
Ca
te
ni
n
Anagen (35) Catagen (P42) Telogen (P49)
IFE
Der
ORS HS
Adp
AR
IFE
HC
Der
AR
SG
Bu
Mx
DP Adp
SG
HSBu
AR
IFE
Der
SG
AR
PCo
Me
Mx
Adp
DP
Bu
GC
ES
DP HGDP
Der
AR
Dp
Mx
β-Catenin β-Catenin
β-Cateninβ-Catenin β-Catenin
a b
c d e
Figure 1. Reciprocal epidermal androgen receptor (AR) and β-catenin activity. (a–e) Wild-type mouse skin stained for AR (green) and β-catenin (red). Gray scale
images of AR and β-catenin labeling are also shown. Bar= 30 μm. Adp, adipocyte; Bu, bulge; Der, dermis; DP, dermal papilla; ES, epithelial strand; GC, germ
capsule; HC, hair canal; HG, hair germ; HS, hair shaft; IFE, interfollicular epidermis; Me, medulla; Mx, matrix; ORS, outer root sheath; PCo, pre-cortex; SG,
sebaceous gland.
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not reported to have a plasma membrane localization
(Bennett et al., 2010).
At postnatal day 2, β-catenin was enriched in the nucleus of
cells that had cytoplasmic AR (Figure 1a). In all other
epidermal cells, β-catenin was localized to the plasma
membrane, as reported previously (Niemann et al., 2002).
During early anagen (the growth phase of the hair cycle) of
adult skin, nuclear β-catenin was conﬁned to cells of the hair
bulb (Figure 1b). At this stage, the AR was strongly localized
in the nucleus of hair bulb cells adjacent to the DP, indicating
active AR signaling, but also detectable in the cytoplasm
(Figure 1b). During full anagen, β-catenin was nuclear in
upper bulb cells of the follicle, whereas the AR was localized
to the cytoplasm (Figure 1c). Conversely, nuclear β-catenin
was absent in the base of catagen HFs (Figure 1d), indicating
downregulation of canonical Wnt signaling. Here the AR was
strongly localized to the nucleus, suggesting activated
signaling. In telogen, β-catenin was only detectable at the
cell membrane, whereas the AR was nuclear (Figure 1e).
During all hair cycle stages, the AR was localized to the
nucleus of DP cells and other dermal ﬁbroblasts, whereas β-
catenin was barely detectable in dermal cells (Figure 1a–e).
In summary, during phases of hair growth, β-catenin was
strongly nuclear in the hair bulb, whereas it localized to the
cell membrane and cytoplasm during hair regression (cata-
gen) or rest (telogen). Conversely, the AR was mainly nuclear
during telogen, catagen, and early anagen but predominantly
cytoplasmic in the hair bulb adjacent to the DP during HF
morphogenesis and full anagen.
To complement the immunolocalization studies, we
examined AR and β-catenin levels in published gene
expression proﬁles of back skin epidermal and dermal cells
isolated by ﬂow cytometry at different stages of HF develop-
ment and homeostasis (Supplementary Figure S1a online;
Collins et al., 2011). The epidermal cells were α6 integrin-
positive, undifferentiated cells from IFE, SG, and HF, whereas
the dermal cells were Pdgfrα-positive cells from all dermal
compartments, including the DP. In the epidermis, AR
expression was highest in telogen keratinocytes, lower in
anagen keratinocytes and keratinocytes from the skin with β-
catenin-induced ectopic HFs, and least abundant in neonatal
keratinocytes. In the dermis, AR levels were highest in adult
telogen and anagen ﬁbroblasts and lowest in neonatal
ﬁbroblasts and ﬁbroblasts from the skin with ectopic HFs. β-
catenin also showed dynamic expression in the epidermis and
dermis, but the variation was less pronounced than in the case
of the AR (Supplementary Figure S1a online). The Wnt/β-
catenin target genes Cd44, Tcf7l1, Tnc, Cux1, Wnt5a, Lgr5,
Lef1, and Dlx3 were upregulated in the epidermis during HF
growth (neonatal, anagen, ectopic HF skin) compared with
telogen (Supplementary Figure S1b online), whereas AR target
genes Ppara, Fabp4, Abca1, and Scp2 (Schirra et al., 2005)
were consistently downregulated under these conditions
(Supplementary Figure S1c online).
The changes in subcellular localization of AR and β-catenin
and the trend toward an inverse relationship between the
levels of AR and β-catenin target genes in keratinocytes and
dermal ﬁbroblasts during hair morphogenesis and cycling
suggest a functional interaction between both proteins.
AR modulates Wnt/β-catenin signaling in cultured human
sebocytes
In human and mouse skin, AR activity is highest in the SG,
where it regulates lipid synthesis and accumulation (Imperato-
McGinley et al., 1993; Zouboulis et al., 2007). We have
recently shown that AR positively regulates murine SG
differentiation in concert with c-MYC (Cottle et al., 2013), a
known Wnt/β-catenin target gene (He et al., 1998). These
observations suggested that cultured sebocytes would be a
good model in which to examine whether in the epidermis, as
in the prostate, the AR negatively regulated Wnt signaling. We
therefore transfected immortalized human sebocytes (Seb-
E6E7 cells; Lo Celso et al., 2008; Cottle et al., 2013) with the
TOPFLASH Wnt activity reporter containing wild-type TCF
binding sites, or with the FOPFLASH reporter containing
mutant TCF binding sites as a negative control (van de
Wetering et al., 1996). Cells were co-transfected with a
Renilla luciferase reporter to adjust for transfection efﬁciency.
The testosterone concentration used (20 μM) has previously
been shown to activate exogenous AR in AR-Luciferase assays
(Cottle et al., 2013). Testosterone is ~ 100-fold less potent
compared with its active form, dihydroxytestosterone.
In Seb-E6E7 cells treated with the AR activator testosterone,
there was no signiﬁcant decrease in luciferase reporter activity
compared with the DMSO control. However, application
of the anti-androgen bicalutamide caused a signiﬁcant
increase in luciferase activity, indicating that AR signaling
negatively regulates endogenous Wnt/β-catenin activity
(Supplementary Figure S2 online). Application of a
combination of testosterone and bicalutamide decreased
luciferase reporter activity to the same level as the DMSO
control, consistent with previous reports showing that
testosterone and bicalutamide compete for AR binding (Furr
and Tucker, 1996). We conclude that AR acts as an antagonist
of Wnt/β-catenin-dependent transcription in epidermal cells
in vitro.
AR modulates epidermal responses to β-catenin-induced anagen
and ectopic HF formation
The ΔK5ΔNβ-cateninER transgenic mice express a stabilized
form of β-catenin in the hair germ and SGs (Baker et al., 2010),
two sites of high AR activity in the skin (Figure 2a and b). To
analyze whether the intracellular localization of AR was altered
in this experimental setting, we stained the back skin of 4-
OHT-treated ΔK5ΔNβ-cateninER transgenic mice with an
antibody against the AR (Supplementary Figure S3a online).
Control (acetone-only treated) tissue showed nuclear AR
expression in all epidermal cells and all dermal ﬁbroblasts,
including DP cells (Supplementary Figure S3a online). In
addition, transgene-negative mice treated with 4-OHT did not
display any changes in AR expression (data not shown). After
4-OHT treatment of ΔK5ΔNβ-cateninER mice for 7 days (3
doses), HFs entered anagen (Supplementary Figure S3a online).
The AR was present in the cytoplasm of hair bulb cells but
remained nuclear in adjacent DP cells. Upon sustained
K Kretzschmar et al.
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epidermal stabilization of β-catenin with 4-OHT for 21 days (9
doses), ectopic HFs formed from most SGs, which showed
strong cytoplasmic AR (Supplementary Figure S3a online).
In order to conﬁrm that these effects were a speciﬁc
response to β-catenin activation, we also stained back skin
sections of two other ΔNβ-cateninER transgenic mouse lines
(Supplementary Figure S3b and c online). In K15ΔNβ-
cateninER transgenic mice, in which stabilized β-catenin is
speciﬁcally expressed in the HF bulge (Baker et al., 2010), 4-
OHT-induced anagen resulted in AR localization only in the
cytoplasm of cells in the lower HF (Supplementary Figure S3b
online). Cells of the IFE and SG were unaffected and still had
nuclear AR (Supplementary Figure S3b online). In K14ΔNβ-
cateninER transgenic mice, in which β-catenin is activated in
the entire epidermal basal layer and the SG (Lo Celso et al.,
2004), AR was localized to the cytoplasm of all epidermal
cells on 4-OHT treatment (Supplementary Figure S3c online).
Thus, β-catenin-induced anagen and ectopic HF formation
correlated with re-localization of the AR from the nucleus to
the cytoplasm but only in those cells that expressed activated
β-catenin. This is consistent with the changes in AR
localization that occur during the normal hair growth cycle
(Figure 1a–f).
Epidermal AR activity can be modulated through topical
application of the androgen testosterone or the anti-androgen
bicalutamide (Cottle et al., 2013). The concentration of
bicalutamide used was insufﬁcient to induce anagen in
wild-type skin so that we could examine the speciﬁc impact
of transgene-dependent signaling events. We treated
ΔK5ΔNβ-cateninER transgenic mice daily with 4-OHT in
combination with these compounds for up to 14 days
(Figure 2b–d). Quantitative real-time reverse-transcriptase–
PCR (QRT-PCR) showed that ArmRNA expression was similar
in all conditions (Figure 2e), indicating that AR activity rather
than expression was altered. In contrast, expression of
endogenous Ctnnb1 mRNA was upregulated in the skin
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treated with 4-OHT or 4-OHT and bicalutamide and down-
regulated by testosterone treatment (Figure 2e).
Transgenic mice treated with acetone (carrier), bicaluta-
mide or testosterone alone, or wild-type mice treated with 4-
OHT in combination with either drug, remained in telogen
(Figure 2f, j, and n and Supplementary Figures S3d and S4g–p
online). The proportion of telogen HF was not signiﬁcantly
different in acetone-treated skin compared with skin treated
with 4-OHT and testosterone, which is consistent with the
inhibitory effect of AR on β-catenin signaling (Figure 2n). In
contrast, 4-OHT application to transgenic mice induced
anagen within 7 days (Figure 2g and n) and conversion of
SGs into ectopic HFs within 14 days (Figure 2k and
Supplementary Figure S4e and f online), as reported
previously (Baker et al., 2010). Combined application of 4-
OHT and bicalutamide stimulated existing HFs to enter
anagen earlier than treatment with 4-OHT alone (Figure 2h
and n and data not shown). Ectopic HFs formed within
14 days (Figure 2l), but there was a striking impairment of hair
shaft formation causing large cysts ﬁlled with keratinized cells
to form in the hair bulbs (Figure 2l and Supplementary Figure
S4a and b online). Full anagen induction was signiﬁcantly
reduced in skin treated with 4-OHT and bicalutamide
compared with 4-OHT alone, reﬂecting the formation of HF
cysts (Figure 2n). Conversely, treating transgenic mice with 4-
OHT in combination with testosterone for 14 days retarded
anagen induction and blocked ectopic HF formation (Figure
2i, m, and n and Supplementary Figure S4c and d online). All
of the effects were observed in both male and female mice
(e.g., Supplementary Figure S4 online).
β-catenin-induced anagen and ectopic HF formation are
correlated with the stimulation of epidermal cell proliferation,
as evaluated by increased expression of Ki67 and proliferating
cell nuclear antigen (Lo Celso et al., 2004; Baker et al., 2010;
Figure 2o–w). Similarly, combined treatment of bicalutamide
and 4-OHT showed increased expression of both markers
(Figure 2o, r, and v). In contrast, application of testosterone in
combination with 4-OHT decreased Ki67 and proliferating
cell nuclear antigen expression (Figure 2o, s and w).
We conclude that AR negatively regulates β-catenin-
induced proliferation, anagen induction, and ectopic HF
formation in mouse skin.
AR activation blocks β-catenin target gene expression and
conversion of SGs into ectopic HFs
We next examined the effects of AR modulation on
expression of β-catenin target genes and markers of HF and
SG differentiation. Application of 4-OHT alone or in
combination with bicalutamide resulted in high levels of
expression of LEF1, which is a well-established epidermal β-
catenin target gene, in the hair bulb and ectopic HFs
(Figure 3a), whereas on combined application of 4-OHT
and testosterone most HFs lacked detectable levels of LEF1
(Figure 3a). Immunolocalization of SOX-9 (Nowak et al.,
2008) and K15 within the bulge was unaffected by treatment
with 4-OHT alone or in combination with bicalutamide or
testosterone (Figure 3b and Supplementary Figure S5a online).
However, total epidermal Sox9 mRNA levels were increased
by 4-OHT alone or in combination with bicalutamide and
decreased on testosterone treatment (Figure 3f). The same
effects were observed on mRNA levels of other β-catenin
target genes (Tcf7l1, Tcf7l2, Cux1, Cdh3, Axin2, Ccnd1,
c-Myc, Wnt5a, Frmd4a, and Bmp2; Figure 3f and
Supplementary Figure S5c online). Although Ccnd1 is a
well-established Wnt/β-catenin target gene, it has also been
reported to be an AR target gene in mouse skin (Schirra et al.,
2005), making it a particularly appropriate readout of the
antagonist effect of AR on Wnt/β-catenin signaling. The
increases in Bmp4 and Ptgs2 were not statistically signiﬁcant,
but both genes were signiﬁcantly downregulated upon
testosterone treatment (Supplementary Figure S5c online).
Conversely, Filamin A (FlnA), which is required for AR
activation in response to androgen stimulation (Castoria et al.,
2011; Mooso et al., 2012), was signiﬁcantly downregulated
by β-catenin activation, an effect that was antagonized by
testosterone (Supplementary Figure S5c online). The observa-
tion that testosterone increased FlnA expression in the
presence of 4-OHT is consistent with the conclusion that
AR signaling antagonized β-catenin signaling. As 4-OHT
treatment led to a major reduction in FlnA, it is not surprising
that there was no further effect of bicalutamide.
CDP (CCAAT displacement protein) is expressed in the HF
bulb during Wnt-driven anagen (Silva-Vargas et al., 2005;
Figure 3c). On bicalutamide treatment, the expanded outer
root sheath and cysts developing from the hair bulb were
strongly positive for CDP (Figure 3c). The cysts expressed the
hair shaft marker K31, which is indicative of HF differentiation
(Figure 3d). Staining for glycogen synthase kinase 3β, an
antagonist of β-catenin and component of its degradation
complex (Clevers and Nusse, 2012), was reduced in HF cysts
by combined application of 4-OHT and bicalutamide
compared with 4-OHT alone, suggesting that the activity of
the β-catenin destruction complex was decreased (Figure 3e).
AR activation blocks conversion of SGs into ectopic HFs
In ΔK5ΔNβ-cateninER back skin ectopic HFs arise exclusively
from the SGs, and this correlates with loss of expression of
fatty acid synthase (FAS), encoded by Fasn, which is an AR
target gene expressed in differentiating sebocytes (Figure 4a
and b; Cottle et al., 2013). Treatment with bicalutamide and
4-OHT also led to a loss of FAS and conversion of the SG to
CDP-positive ectopic HFs (Figure 4a–c and e). Conversely, 4-
OHT and testosterone-treated back skin from ΔK5ΔNβ-
cateninER mice showed preservation of FAS-positive sebo-
cytes and a reduction in ectopic HFs (Figure 4a–c and e).
QRT-PCR analysis conﬁrmed that expression of Fasn and
another sebocyte marker, Fabp5, was reduced in
bicalutamide-treated skin, indicating the loss of sebocyte
differentiation (Figure 4d). In addition to being expressed in
the SG, FAS was expressed in the cuticle layer of anagen HFs
(Supplementary Figure S5d online), explaining the increase in
Fasn expression in transgenic mice treated with 4-OHT only
(Figure 4d). B lymphocyte–induced maturation protein 1,
which is expressed by terminally differentiated keratinocytes
in several epidermal compartments (Cottle et al., 2013;
Kretzschmar et al., 2014), was no longer expressed in
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sebocytes following combined application of 4-OHT and
bicalutamide (Supplementary Figure S5b online).
AR modulates the effects of epidermal β-catenin on the dermis
Hair cycling and ectopic HF formation are controlled by
interactions between the epidermis and dermis (Driskell et al.,
2011; 2012). Epidermal β-catenin activation in adult skin
reprograms the dermis to a neonatal state characterized
by increased ﬁbroblast proliferation and density, and
extracellular matrix remodeling (Collins et al., 2011).
Dermal thickness in ΔK5ΔNβ-cateninER skin increased on
treatment with 4-OHT alone or in combination with
bicalutamide (Figure 5g), as has been reported for wild-type
anagen skin (Hansen et al., 1984; Müller-Röver et al., 2001).
Sustained β-catenin activation in combination with AR
inhibition led to an increase in platelet-derived growth
factor receptor-α-positive (Figure 5a) and Vimentin-positive
(Figure 5d) ﬁbroblasts adjacent to ectopic HFs. In addition, the
hyaluronic acid receptor CD44, which is a Wnt/β-catenin
target gene (Wielenga et al., 1999), was markedly increased
around cysts induced by combined 4-OHT and bicalutamide
treatment (Figure 5b). Next, we visualized mature (bright pink)
and immature collagen (blue) using Herovici’s method
(Figure 5c). Extracellular matrix remodeling occurred in the
presence of bicalutamide but was inhibited by testosterone
(Figure 5c). The DP of anagen HFs expressed Corin (Figure 5e;
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Driskell et al., 2009). However, Corin was not expressed in
the cysts that were induced by 4-OHT in combination with
bicalutamide (Figure 5e). Quantitation of hematoxylin and
eosin stained images revealed that only about 25% of hair
bulbs had associated DP (Figure 5h), suggesting that cyst
formation caused disintegration of the normal hair bulb.
Melanoblasts reside in the secondary hair germ and bulge
and are required for hair pigmentation during anagen
(Nishimura et al., 2002). Melanoblasts are stimulated to
proliferate through epidermal β-catenin activation (Rabbani
et al., 2011). Anagen HFs in the back skin of transgenic mice
treated with 4-OHT showed expression of the melanocyte
marker TRP2 (tyrosinase-related protein 2) in melanocytes
within the DP-associated matrix of the hair bulge (Figure 5f).
Sustained β-catenin activation in transgenic mice treated with
4-OHT and bicalutamide showed that TRP2-positive mela-
nocytes were relocated to the periphery of HF cysts
(Figure 5f). Surprisingly, TRP2-positive cells were also present
in ectopic HFs, suggesting a further maturation than
previously achieved (Figure 5f).
These data show that AR activity not only controls
epidermal sensitivity to β-catenin stabilization but also
regulates the effects of epidermal β-catenin activation on
melanocytes and dermal ﬁbroblasts (Figure 5i). Taken
together, our results suggest that AR acts as a negative
regulator of both the cell-autonomous and non-cell-
autonomous effects of epidermal Wnt/β-catenin signaling in
adult mouse skin.
DISCUSSION
Previous studies have shown that AR activity regulates the
hair cycle and contributes to the pathogenesis of AGA (Paus
and Cotsarelis, 1999). AR knockout mice have a disturbed
hair growth cycle (Naito et al., 2008), as do mice in which AR
is overexpressed in the epidermis (Crabtree et al., 2010). We
now demonstrate that one mechanism by which AR regulates
the hair cycle is by inhibiting Wnt/β-catenin signaling in adult
mouse epidermis.
AR and β-catenin exhibited partially inverse activity and
expression during the hair cycle. AR negatively regulated β-
catenin transcriptional activity and target gene expression,
whereas β-catenin activation led to inhibition of AR activity,
as evaluated by relocation of AR from the nucleus to the
cytoplasm, which is associated with inhibition of AR signaling
(Azzi et al., 2006; Cottle et al., 2013). These observations
point to the existence of a feedback loop that controls the
hair cycle. The partially reversed subcellular localization
of AR and β-catenin during the hair cycle suggests that
their interaction may be predominantly indirect. The
downregulation of glycogen synthase kinase 3β on AR
inhibition would, for example, affect β-catenin protein
stability, whereas the decreased expression of Filamin A as
a result of β-catenin activation would reduce AR activation in
response to androgen stimulation (Castoria et al., 2011;
Mooso et al., 2012).
The fact that we did not see any phenotypic effects of AR
modulation in vivo in the absence of exogenous β-catenin
activation further supports the view that AR negatively
regulates β-catenin target genes by indirect mechanisms.
Among negative regulators of Wnt/β-catenin signaling in HF
stem cells, microRNAs such as microRNA-214 have been
identiﬁed (Ahmed et al., 2014). Interestingly, in the prostate of
castrated rats, microRNA-214 expression is positively corre-
lated by androgen action (Narayanan et al., 2010), suggesting
one mechanism of indirect regulation of β-catenin expression
through AR activity. Collectively, these results suggest that the
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interaction between AR and β-catenin could be both
transcriptional and post-translational.
Epidermal β-catenin activation not only stimulates expan-
sion of the stem cell compartment and differentiation along
the HF lineages (Watt and Collins, 2008) but also stimulates
melanocyte differentiation (Rabbani et al., 2011) and
reprogramming of the dermis to a neonatal state characterized
by extracellular matrix remodeling and ﬁbroblast proliferation
(Collins et al., 2011). All of these effects, both cell-autonomous
and non-cell-autonomous, were inhibited by AR signaling.
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Prolonged activation of β-catenin in the epidermis pro-
motes the formation of benign HF tumors called trichofolli-
culomas (Gat et al., 1998; Lo Celso et al., 2004; Närhi et al.,
2008). The effect of sustained β-catenin stabilization in the
presence of AR inhibition was to cause defects in hair
shaft formation and development of cysts resembling
trichofolliculomas (Figure 3d; Pálmer et al., 2008). As AR
inhibition by bicalutamide increases Wnt pathway activity
in vitro and also causes a signiﬁcant increase in expression of
β-catenin target genes such as Axin2 and Tcf1l7 (TCF3), we
believe that cyst formation in our model is triggered by a
further upregulation of Wnt/β-catenin signaling through the
increased activity of the ΔNβ-catenin transgene. The cyst
phenotype is compatible with the concept that proliferation
becomes to some extent uncoupled from differentiation, due
to AR inhibition resulting in increased Wnt activity. The strong
upregulation of CD44 by the combination of 4-OHT and
bicalutamide is also interesting, as CD44 has previously been
identiﬁed as a component of tumor stroma that promotes
tumor growth and spread (Edward et al., 2005). Thus, our
ﬁndings may also provide insights into the formation of HF
tumors and other Wnt-driven cancers.
In summary, we have identiﬁed the AR as an intracellular
regulator of epidermal β-catenin signaling in adult mice. The
mechanistic insights are potentially relevant to human HF
disorders and diseases, such as AGA and trichofolliculomas,
where the balance between antagonistic AR and β-catenin
signaling may be disturbed. Nevertheless, there are undoubt-
edly differences between AR activity in mouse and human
skin. None of the effects in mouse skin were gender speciﬁc,
in agreement with our previous study (Cottle et al., 2013). This
is in contrast to the role of AR in human HFs, where the effects
of AR appear to be context- and gender-dependent: andro-
gens stimulate beard growth beginning with the onset of male
puberty but inhibit scalp hair growth in AGA (Inui and Itami,
2013).
MATERIALS AND METHODS
Generation and experimental treatment of mice
Experiments were performed in accordance with the UK Government
Animals (Scientiﬁc Procedures) Act 1986 and subject to institutional
ethics approval. All transgenic mice have been described previously
(Lo Celso et al., 2004; Baker et al., 2010). At the start of every
experiment mice were 7–8-weeks old and in telogen (Stenn and
Paus, 2001). The ΔNβ-cateninER transgene was activated by topical
application of 4-OHT (Sigma St. Louis, MO) as described previously
(Baker et al., 2010). To modulate AR signaling, mice were treated
daily for up to 14 days with 4-OHT (in 100 μl acetone) alone or in
combination with 2mg bicalutamide (Casodex, Sigma; dissolved in
100 μl acetone) or 2 mg testosterone (Sigma; dissolved in 100 μl
acetone; Cottle et al., 2013). In experiments in which the effect of 4-
OHT alone was compared with 4-OHT and testosterone or
bicalutamide, the volume of 4-OHT applied to mice treated with
4-OHT alone was made up to 200 μl with acetone. The effects of the
drugs on mouse skin have been validated previously Cottle et al.,
2013). Wild-type littermates and acetone-treated transgenic mice
were used as controls in all experiments. At least three mice,
matched in gender and age (littermates), were treated per condition.
No gender-speciﬁc effects were observed.
Gene expression analysis
For microarray analysis of dermal ﬁbroblasts and epidermal
keratinocytes isolated from different HF stages, gene expression
proﬁles published in the study by Collins et al. (2011) and deposited
under accession number GSE32966 on NCBI’s Gene Expression
Omnibus (GEO) website were analyzed with GeneSpring GX11
(Agilent, Santa Clara, CA).
Human sebocyte culture, transfection, and luciferase assays
The Seb-E6E7 line of immortalized human SG cells has been
described elsewhere (Lo Celso et al., 2008; Cottle et al., 2013).
Details of transfection methods, constructs, and luciferase analysis
are provided in the Supplementary Materials online.
RNA extraction and QRT-PCR
RNA isolation (using the Trizol method), cDNA synthesis, and QRT-PCR
were performed as described in the Supplementary Materials online.
Histology, immunohistochemistry, and imaging
Tissue samples for sections were ﬁxed overnight in 4% paraformalde-
hyde and embedded in parafﬁn wax. Antibodies and labeling pro-
cedures are described in the Supplementary Materials online. Image
analysis was performed using a Leica TCS SP5 confocal microscope
(Wetzlar, Germany) (ﬂuorescence microscopy) or a Zeiss Axiophot
microscope equipped with a Zeiss AxioCam HRc camera (Oberko-
chen, Germany) (hematoxylin and eosin and Herovici staining).
Quantitation and statistical analysis
Quantitation of changes in the epidermis is described in the
Supplementary Materials online. Statistical analysis was performed
using the unpaired Student’s t-test. P-values of o0.05 were
considered statistically signiﬁcant.
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